Circio Holding is trading 9.16% up now at NOK 11.92 after its August 25 extraordinary general meeting approved the election of Dr. Dinah Sah and Dr. Robert Burns to the board.

  • The meeting also renewed authorization to increase share capital.
  • Sah brings RNA and gene-therapy experience; Circio said the strengthened board supports its next development phase and potential clinical entry in 2029.
  • The announcement did not explicitly attribute the rise to the meeting; broader biotech strength, with XBI up 2.06%, may have added support.